These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16930379)

  • 1. The weight of evidence for ropinirole in restless legs syndrome.
    Trenkwalder C
    Eur J Neurol; 2006 Oct; 13 Suppl 3():21-30. PubMed ID: 16930379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole treatment for restless legs syndrome.
    Chitnis S
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):655-64. PubMed ID: 18484922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole treatment for restless legs syndrome.
    Molnar MZ; Fornadi K; Shapiro CM
    Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Bogan RK; Fry JM; Schmidt MH; Carson SW; Ritchie SY;
    Mayo Clin Proc; 2006 Jan; 81(1):17-27. PubMed ID: 16438474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials.
    Hansen RA; Song L; Moore CG; Gilsenan AW; Kim MM; Calloway MO; Murray MD
    Pharmacotherapy; 2009 Mar; 29(3):255-62. PubMed ID: 19249945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
    Trenkwalder C; Garcia-Borreguero D; Montagna P; Lainey E; de Weerd AW; Tidswell P; Saletu-Zyhlarz G; Telstad W; Ferini-Strambi L;
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):92-7. PubMed ID: 14707315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer dopamine agonists in the treatment of restless legs syndrome.
    Weimerskirch PR; Ernst ME
    Ann Pharmacother; 2001 May; 35(5):627-30. PubMed ID: 11346069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome in women: a review.
    Thomas K; Watson CB
    J Womens Health (Larchmt); 2008 Jun; 17(5):859-68. PubMed ID: 18537487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.
    Benes H; Mattern W; Peglau I; Dreykluft T; Bergmann L; Hansen C; Kohnen R; Banik N; Schoen SW; Hornyak M
    J Neurol; 2011 Jun; 258(6):1046-54. PubMed ID: 21188406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.